Investigational Drug Information for Pridopidine
✉ Email this page to a colleague
What is the drug development status for Pridopidine?
Pridopidine is an investigational drug.
There have been 10 clinical trials for Pridopidine.
The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2008.
The most common disease conditions in clinical trials are Huntington Disease, Motor Neuron Disease, and Amyotrophic Lateral Sclerosis. The leading clinical trial sponsors are Prilenia, Teva Branded Pharmaceutical Products, R&D Inc., and Merit E. Cudkowicz, MD.
Summary for Pridopidine
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 175 |
WIPO Patent Applications | 81 |
Japanese Patent Applications | 33 |
Clinical Trial Progress | Phase 3 (2008-04-01) |
Vendors | 67 |
Recent Clinical Trials for Pridopidine
Title | Sponsor | Phase |
---|---|---|
HEALEY ALS Platform Trial - Regimen D Pridopidine | Prilenia Therapeutics | Phase 2/Phase 3 |
HEALEY ALS Platform Trial - Regimen D Pridopidine | Merit E. Cudkowicz, MD | Phase 2/Phase 3 |
PRidopidine's Outcome On Function in Huntington Disease, PROOF- HD | Prilenia | Phase 3 |
Clinical Trial Summary for Pridopidine
Top disease conditions for Pridopidine
Top clinical trial sponsors for Pridopidine
US Patents for Pridopidine
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |